Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. (PHAT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHAT · as of Jun 9, 2026
Key Statistics
Explore Phathom Pharmaceuticals, Inc. Data
phat stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 88.9%
The PHAT analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $24.67, representing +146.70% upside from the current price of $10.00.
Competitors & Peers
phat competitorsPHAT
ANAB
BBOT
BCAX
KOD
NRIXStock Performance
Full HistoryAbout Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company i…
what is phathom pharmaceuticals, inc. · phat stock overview · phathom pharmaceuticals, inc. company profile · who is phathom pharmaceuticals, inc. ceo · phat NASDAQ · phathom pharmaceuticals, inc. headquarters · phathom pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Phathom Pharmaceuticals, Inc. (PHAT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 25, 2019. As of the latest trading session, PHAT stock price is $10.00, with a market capitalization of $797.6M. The stock has returned +13.25% over the past 12 months and -39.72% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Phathom Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $24.67. In fiscal year 2025, Phathom Pharmaceuticals, Inc. reported revenue of $175.1M and net income of -$221.2M. For detailed data — including Phathom Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Phathom Pharmaceuticals, Inc. (PHAT) stock price is $10.00. The stock is traded on NASDAQ under the ticker symbol PHAT. The 52-week range is $7.61 – $18.31.